|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Invivoscribe Technologies, Inc.
| | | Phone: | (858) 224-6600 | Fax: | (858) 224-6601 | Year Established: | 1995 | Main Contact: | Jeffrey E. Miller, Ph.D, Co-Founder, CSO & CEO | | Other Contacts: | Jordan Thornes, Director of Quality Assurance Karen Vane, Senior Director, Quality Assurance Bradley Patay, M.D., CMO Meghna Bhatnagar, CFO Timothy T. Stenzel, M.D., Ph.D., FCAP, COO
| | Company Description | Invivoscribe, through its wholly-owned subsidiaries LabPMM, is a leading provider of clinically-validated personalized molecular diagnostics. The company and its subsidiaries provide one stop comprehensive care for patients in over 50 countries. Invivoscribe's CE-marked IVD products are used to identify, classify and monitor leukemias, lymphomas and other lymphoproliferative diseases. The company's CLIA- and CAP-accredited clinical reference laboratories, LabPMM LLC & LabPMM GmbH, are the only clinical laboratories outside Japan licensed to perform FLT3 biomarker testing, and the only laboratories in the world licensed to determine the mutation status of both FLT3 and NPM1. | |
|
|
|
|
|